當前位置：首頁 JCRQ2 期刊介紹(非官網)

Frontiers Of MedicineSCIE

國際簡稱：FRONT MED-PRC 參考譯名：醫學前沿

中科院分區
3區
CiteScore分區
Q1
JCR分區
Q2

基本信息：: ISSN：2095-0217; E-ISSN：2095-0225; 是否OA：未開放; 是否預警：否; TOP期刊：否

出版信息：: 出版地區：PEOPLES R CHINA; 出版商：Higher Education Press; 出版語言：English; 出版周期：6 issues per year; 出版年份：2007; 研究方向：ONCOLOGYMEDICINE, RESEARCH & EXPERIMENTAL&-MEDICINE, RESEARCH & EXPERIMENTAL

評價信息：: 影響因子：3.9; H-index：28; CiteScore指數：18.3; SJR指數：1.468; SNIP指數：1.265

發文數據：: Gold OA文章占比：9.22%; 研究類文章占比：72.73%; 年發文量：77; 自引率：0; 開源占比：0.1362; 出版撤稿占比：0; 出版國人文章占比：0.73; OA被引用占比：0.4922...

投稿咨詢加急見刊

英文簡介期刊介紹 CiteScore數據中科院SCI分區 JCR分區發文數據常見問題

英文簡介Frontiers Of Medicine期刊介紹

Frontiers of Medicine is an international general medical journal sponsored by the Ministry of Education of China. The journal is jointly published by the Higher Education Press and Springer. Online versions are available through http://link.springer.com/. Since the first issue of 2010, this journal has been indexed in PubMed/MEDLINE.

Frontiers of Medicine is dedicated to publishing original research and review articles on the latest advances in clinical and basic medicine with a focus on epidemiology, traditional Chinese medicine, translational research, healthcare, public health and health policies. The journal employs a rigorous peer-review and editing process to ensure the scientific accuracy, novelty and importance of the manuscripts. Frontiers of Medicine is committed to promoting health and health care through communications among professionals in medical care, disease prevention and scientific research throughout the world by updating the progress in medicine, sharing experiences in disease control and treatment and exchanging views on health policies, medical services and health care reform.

期刊簡介Frontiers Of Medicine期刊介紹

《Frontiers Of Medicine》自2007出版以來，是一本醫學優秀雜志。致力于發表原創科學研究結果，并為醫學各個領域的原創研究提供一個展示平臺，以促進醫學領域的的進步。該刊鼓勵先進的、清晰的闡述，從廣泛的視角提供當前感興趣的研究主題的新見解，或審查多年來某個重要領域的所有重要發展。該期刊特色在于及時報道醫學領域的最新進展和新發現新突破等。該刊近一年未被列入預警期刊名單，目前已被權威數據庫SCIE收錄，得到了廣泛的認可。

該期刊投稿重要關注點：

預計審稿時間：
醫學
MEDICINE, RESEARCH & EXPERIMENTAL
SCIE
中科院3區
非預警

Cite Score數據（2024年最新版）Frontiers Of Medicine Cite Score數據

CiteScore：18.3
SJR：1.468
SNIP：1.265

學科類別	分區	排名	百分位
大類：Medicine 小類：General Medicine	Q1	17 / 636	97%

CiteScore 是由Elsevier(愛思唯爾)推出的另一種評價期刊影響力的文獻計量指標。反映出一家期刊近期發表論文的年篇均引用次數。CiteScore以Scopus數據庫中收集的引文為基礎，針對的是前四年發表的論文的引文。CiteScore的意義在于，它可以為學術界提供一種新的、更全面、更客觀地評價期刊影響力的方法，而不僅僅是通過影響因子(IF)這一單一指標來評價。

歷年Cite Score趨勢圖

中科院SCI分區Frontiers Of Medicine 中科院分區

中科院 2023年12月升級版 綜述期刊：否 Top期刊：否

大類學科	分區	小類學科	分區
醫學	3區	MEDICINE, RESEARCH & EXPERIMENTAL 醫學：研究與實驗 ONCOLOGY 腫瘤學	3區 4區

中科院分區表 是以客觀數據為基礎，運用科學計量學方法對國際、國內學術期刊依據影響力進行等級劃分的期刊評價標準。它為我國科研、教育機構的管理人員、科研工作者提供了一份評價國際學術期刊影響力的參考數據，得到了全國各地高校、科研機構的廣泛認可。

中科院分區表 將所有期刊按照一定指標劃分為1區、2區、3區、4區四個層次，類似于“優、良、及格”等。最開始，這個分區只是為了方便圖書管理及圖書情報領域的研究和期刊評估。之后中科院分區逐步發展成為了一種評價學術期刊質量的重要工具。

歷年中科院分區趨勢圖

JCR分區Frontiers Of Medicine JCR分區

2023-2024 年最新版

按JIF指標學科分區	收錄子集	分區	排名	百分位
學科：MEDICINE, RESEARCH & EXPERIMENTAL	SCIE	Q2	64 / 189	66.4%
學科：ONCOLOGY	SCIE	Q2	99 / 322	69.4%

按JCI指標學科分區	收錄子集	分區	排名	百分位
學科：MEDICINE, RESEARCH & EXPERIMENTAL	SCIE	Q2	64 / 189	66.4%
學科：ONCOLOGY	SCIE	Q2	102 / 322	68.48%

JCR分區的優勢在于它可以幫助讀者對學術文獻質量進行評估。不同學科的文章引用量可能存在較大的差異，此時單獨依靠影響因子(IF)評價期刊的質量可能是存在一定問題的。因此，JCR將期刊按照學科門類和影響因子分為不同的分區，這樣讀者可以根據自己的研究領域和需求選擇合適的期刊。

歷年影響因子趨勢圖

發文數據

2023-2024 年國家/地區發文量統計

國家/地區數量
CHINA MAINLAND226
USA37
England7
Australia5
South Korea5
France4
GERMANY (FED REP GER)3
Japan3
Canada2
Italy2

本刊中國學者近年發表論文

1、CD47 blockade improves the therapeutic effect of osimertinib in non-small cell lung cancer
Author: Yu, Wei-Bang; Chen, Yu-Chi; Huang, Can-Yu; Ye, Zi-Han; Shi, Wei; Zhu, Hong; Shi, Jia-Jie; Chen, Jun; Lu, Jin-Jian

Journal: FRONTIERS OF MEDICINE. 2023; Vol. 17, Issue 1, pp. 105-118. DOI: 10.1007/s11684-022-0934-1
2、RGS16 regulated by let-7c-5p promotes glioma progression by activating PI3K-AKT pathway
Author: Wang, Chaochao; Xue, Hao; Zhao, Rongrong; Sun, Zhongzheng; Gao, Xiao; Qi, Yanhua; Wang, Huizhi; Xu, Jianye; Deng, Lin; Li, Gang

Journal: FRONTIERS OF MEDICINE. 2023; Vol. 17, Issue 1, pp. 143-155. DOI: 10.1007/s11684-022-0929-y
3、Adjuvant chemotherapy versus adjuvant concurrent chemoradiotherapy after radical surgery for early-stage cervical cancer: a randomized, non-inferiority, multicenter trial
Author: Weng, Danhui; Xiong, Huihua; Zhu, Changkun; Wan, Xiaoyun; Chen, Yaxia; Wang, Xinyu; Zhang, Youzhong; Jiang, Jie; Zhang, Xi; Gao, Qinglei; Chen, Gang; Xing, Hui; Wang, Changyu; Li, Kezhen; Chen, Yaheng; Mao, Yuyan; Hu, Dongxiao; Pan, Zimin; Chen, Qingqin; Cui, Baoxia; Song, Kun; Yi, Cunjian; Peng, Guangcai; Han, Xiaobing; An, Ruifang; Fan, Liangsheng; Wang, Wei; Xiong, Tingchuan; Chen, Yile; Tang, Zhenzi; Li, Lin; Yang, Xingsheng; Cheng, Xiaodong; Lu, Weiguo; Wang, Hui; Kong, Beihua; Xie, Xing; Ma, Ding

Journal: FRONTIERS OF MEDICINE. 2023; Vol. 17, Issue 1, pp. 93-104. DOI: 10.1007/s11684-021-0892-z
4、Achievements of the national malaria control and elimination program in the People's Republic of China: the Atlas of Malaria Transmission in China
Author: Feng, Jun; Zhang, Li; Xia, Zhigui; Zhou, Shuisen; Xiao, Ning; Zhou, Xiao-Nong

Journal: FRONTIERS OF MEDICINE. 2023; Vol. 17, Issue 1, pp. 85-92. DOI: 10.1007/s11684-021-0917-7
5、GDF15 negatively regulates chemosensitivity via TGFBR2-AKT pathway-dependent metabolism in esophageal squamous cell carcinoma
Author: Du, Yingxi; Ma, Yarui; Zhu, Qing; Fu, Yong; Li, Yutong; Zhang, Ying; Li, Mo; Feng, Feiyue; Yuan, Peng; Wang, Xiaobing

Journal: FRONTIERS OF MEDICINE. 2023; Vol. 17, Issue 1, pp. 119-131. DOI: 10.1007/s11684-022-0949-7
6、Association of cardiac disease with the risk of post-lung transplantation mortality in Chinese recipients aged over 65 years
Author: Jiao, Guohui; Ye, Shugao; Zhang, Ji; Wu, Bo; Wei, Dong; Liu, Dong; Liu, Feng; Hu, Chunxiao; Chen, Jingyu

Journal: FRONTIERS OF MEDICINE. 2023; Vol. 17, Issue 1, pp. 58-67. DOI: 10.1007/s11684-022-0937-y
7、Decreasing complexity of glucose time series derived from continuous glucose monitoring is correlated with deteriorating glucose regulation
Author: Li, Cheng; Ma, Xiaojing; Lu, Jingyi; Tao, Rui; Yu, Xia; Mo, Yifei; Lu, Wei; Bao, Yuqian; Zhou, Jian; Jia, Weiping

Journal: FRONTIERS OF MEDICINE. 2023; Vol. 17, Issue 1, pp. 68-74. DOI: 10.1007/s11684-022-0955-9
8、J-shaped association between dietary zinc intake and new-onset hypertension: a nationwide cohort study in China
Author: He, Panpan; Li, Huan; Liu, Mengyi; Zhang, Zhuxian; Zhang, Yuanyuan; Zhou, Chun; Ye, Ziliang; Wu, Qimeng; Liang, Min; Jiang, Jianping; Wang, Guobao; Nie, Jing; Hou, Fan Fan; Liu, Chengzhang; Qin, Xianhui

Journal: FRONTIERS OF MEDICINE. 2023; Vol. 17, Issue 1, pp. 156-164. DOI: 10.1007/s11684-022-0932-3